CURRENT OPINION IN IMMUNOLOGY

Scope & Guideline

Advancing the Frontiers of Immunological Research

Introduction

Welcome to the CURRENT OPINION IN IMMUNOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of CURRENT OPINION IN IMMUNOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0952-7915
PublisherCURRENT BIOLOGY LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1988 to 2024
AbbreviationCURR OPIN IMMUNOL / Curr. Opin. Immunol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Aims and Scopes

CURRENT OPINION IN IMMUNOLOGY serves as a critical platform for discussing the latest advancements and insights in immunology research. The journal focuses on the dynamic interplay between immune responses and various biological systems, emphasizing both basic and applied aspects of immunology.
  1. Immune Response Mechanisms:
    The journal extensively covers the mechanisms underlying immune responses, including the roles of different immune cells, signaling pathways, and the molecular interactions that govern these processes.
  2. Clinical Immunology and Therapeutics:
    A significant portion of the content is dedicated to clinical applications of immunology, particularly in the context of vaccines, cancer immunotherapy, and autoimmune diseases, highlighting translational research.
  3. Microbiome and Immune Interactions:
    Recent publications indicate a growing interest in the relationship between the microbiome and immune function, exploring how microbial communities influence host immune responses and contribute to health and disease.
  4. Innovative Research Techniques:
    The journal features papers that discuss novel methodologies and technologies in immunology research, such as single-cell transcriptomics and advanced imaging techniques, underscoring the importance of innovation in studying immune systems.
  5. Interferon Biology:
    There is a consistent focus on the role of interferons in both innate and adaptive immunity, investigating their diverse functions and regulatory mechanisms across various contexts, including viral infections and chronic diseases.
The journal has also highlighted several emerging themes that reflect current trends in immunology research. These areas are gaining traction and indicate a shift in focus towards more complex and integrative approaches to understanding immunity.
  1. T Follicular Helper Cell Dynamics:
    Papers discussing T follicular helper cells have surged, indicating a growing recognition of their critical role in orchestrating adaptive immune responses, particularly in relation to allergies and vaccine responses.
  2. Interferon Signaling Pathways:
    There is an increasing emphasis on the diverse roles of interferons in both innate and adaptive immunity, particularly in the context of viral infections and cancer, showcasing their importance in therapeutic strategies.
  3. Immunometabolism:
    Research focusing on the metabolic pathways that influence immune cell function is on the rise, highlighting the interplay between metabolism and immunity, which is crucial for understanding immune responses in various diseases.
  4. Microbiome-Immune Interactions:
    The exploration of how microbiota influence immune development and function is becoming a prominent theme, reflecting a broader interest in host-microbe interactions and their implications for health.
  5. Cellular Senescence and Immunity:
    Emerging studies on cellular senescence and its impact on immune function indicate a growing interest in how aging and chronic inflammation affect immune responses, particularly in the context of cancer and autoimmune diseases.

Declining or Waning

While CURRENT OPINION IN IMMUNOLOGY continues to address a wide array of topics, certain themes appear to be less frequently explored in recent publications. This may reflect shifts in research priorities or the emergence of new areas of interest.
  1. Traditional Vaccine Approaches:
    There seems to be a diminishing focus on conventional vaccine strategies as newer technologies, such as mRNA vaccines, gain prominence, suggesting a shift towards innovative vaccine platforms.
  2. Basic Immunological Principles:
    Basic concepts of immunology, while still essential, are receiving less attention compared to applied research and specific immune responses, indicating a trend towards more specialized topics.
  3. Static Models of Immune Function:
    Research employing static or less dynamic models of immune function is becoming less prevalent as the field moves towards understanding the complexities of immune interactions in real-time and in vivo contexts.

Similar Journals

Journal of Immunology Research

Pioneering Immunology: Sharing Knowledge, Shaping the Future
Publisher: HINDAWI LTDISSN: 2314-8861Frequency:

Journal of Immunology Research, published by HINDAWI LTD, stands as a pivotal open-access journal in the realm of immunology, with a particular emphasis on advancing knowledge in both fundamental and applied aspects of the field. Since its inception in 1990, the journal has committed to the dissemination of high-quality research, earning a respectable impact factor that reflects its significance. Based in Egypt, it provides a platform for researchers from around the world, showcasing innovative studies and reviews that contribute to the understanding of immune system mechanisms. Its 2023 rankings place it in the Q2 category for Immunology and Allergy, and Q1 in the broader category of Medicine (miscellaneous), indicating a strong reputation among its peers. Through its open-access model, the journal promotes wide accessibility of cutting-edge research, catering to researchers, professionals, and students alike. With ambitions that converge through 2024, the Journal of Immunology Research continues to be an essential resource for those seeking to explore the forefront of immunological science.

ImmunoTargets and Therapy

Fostering Global Collaboration in Immunology
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

ImmunoTargets and Therapy is a leading open access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of immunology and its various therapeutic applications. Since its inception in 2012, the journal has rapidly become a vital resource for researchers, professionals, and students, achieving notable recognition with a Q1 ranking in both Immunology and Immunology and Allergy categories as of 2023. With an impressive Scopus ranking of #22 out of 233 in Medicine - Immunology and Allergy, and #25 out of 236 in Immunology and Microbiology, this journal maintains a 90th percentile standing in its field. ImmunoTargets and Therapy not only publishes original research articles, reviews, and clinical studies, but also fosters an inclusive platform for the dissemination of innovative findings critical to the fight against immunological disorders. Based in New Zealand, it serves a global audience, promoting knowledge exchange and collaboration through its open access model.

HUMAN IMMUNOLOGY

Illuminating the Pathways of Human Immunology
Publisher: ELSEVIER SCIENCE INCISSN: 0198-8859Frequency: 12 issues/year

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.

CLINICAL IMMUNOLOGY

Unveiling Breakthroughs in Clinical Immunology
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1521-6616Frequency: 12 issues/year

CLINICAL IMMUNOLOGY is a premier academic journal dedicated to the field of immunology, published by Academic Press Inc. Elsevier Science. With a robust impact reflected in its recent categorization as Q2 in Immunology and Q1 in Immunology and Allergy for 2023, this journal stands out as a key resource for researchers and professionals alike. Featuring a diverse array of articles from fundamental laboratory studies to advanced clinical applications, CLINICAL IMMUNOLOGY aims to disseminate significant research findings that contribute to the evolving landscape of immunological science. Its notable Scopus rankings underscore its esteemed position, with ranks of #33 and #36 in the respective categories, highlighting its commitment to high-quality scholarly work. Although not an open-access journal, it ensures access to valuable insights and developments in the immune response and related fields, making it an indispensable tool for students and professionals aiming to stay at the forefront of immunological research.

JOURNAL OF IMMUNOLOGY

Driving Discoveries in Immune Health
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

CANCER IMMUNOLOGY IMMUNOTHERAPY

Advancing the Frontiers of Cancer Treatment
Publisher: SPRINGERISSN: 0340-7004Frequency: 12 issues/year

Cancer Immunology Immunotherapy, published by Springer, stands as a premier journal in the fields of cancer research and immunology, holding a prestigious Q1 ranking across multiple categories, including Oncology and Medicine as of 2023. With an ISSN of 0340-7004 and an E-ISSN of 1432-0851, this journal has been a pivotal platform for groundbreaking research since its inception in 1976, continuing to provide insight into the complex interactions between the immune system and cancer. The journal's scope encompasses a wide array of topics, including novel therapeutic strategies, immunological mechanisms, and translational science aimed at advancing treatment outcomes for cancer patients. Renowned for its rigorous peer-review process and high impact factor, it attracts contributions from leading experts and researchers around the globe, positioning itself among the top-tier publications with Scopus rankings that reflect its vital role in advancing the field. Access options are generally subscription-based, ensuring a comprehensive resource for professionals and academics seeking to deepen their understanding and make meaningful contributions to cancer immunotherapy.

Immuno

Advancing Immunology Through Open Access Innovation
Publisher: MDPIISSN: Frequency: 4 issues/year

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

Immunotherapy Advances

Advancing the frontier of immunology with cutting-edge research.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Immunotherapy Advances, published by Oxford University Press, stands at the forefront of the rapidly evolving field of immunology and microbe interactions, focusing specifically on novel immunotherapeutic strategies and their clinical applications. Established in 2021, this peer-reviewed journal aims to disseminate high-quality research that contributes to the understanding and advancement of immunotherapeutic techniques, potentially transforming patient care in immunology. With a current Scopus rank of #140 out of 236 in the realm of Immunology, placing it in the 40th percentile, Immunotherapy Advances is positioned to be an integral resource for researchers, healthcare professionals, and students eager to stay updated with groundbreaking findings and methodologies. The journal is dedicated to fostering innovative discussions and collaborations, ensuring open access to vital research that influences treatment paradigms globally.

INTERNATIONAL IMMUNOLOGY

Unveiling Innovations in Immunology for Global Impact.
Publisher: OXFORD UNIV PRESSISSN: 0953-8178Frequency: 12 issues/year

INTERNATIONAL IMMUNOLOGY, published by OXFORD UNIV PRESS, stands out as a premier journal in the field of immunology, providing a vital platform for disseminating groundbreaking research and innovative developments within the discipline. With an impressive Q1 ranking in Immunology and Allergy, as well as in Medicine (miscellaneous), it consistently showcases high-impact studies that contribute to the advancement of immunological knowledge. The journal spans over three decades, from its inception in 1989 to its ongoing contributions as of 2024, thus solidifying its reputation in the scientific community. Researchers, professionals, and students will find valuable articles that delve into the complexities of immune responses, therapeutic interventions, and emerging immunological paradigms, ensuring INTERNATIONAL IMMUNOLOGY remains at the forefront of knowledge in the life sciences.

CRITICAL REVIEWS IN IMMUNOLOGY

Fostering Critical Conversations in Immunology
Publisher: BEGELL HOUSE INCISSN: 1040-8401Frequency: 6 issues/year

CRITICAL REVIEWS IN IMMUNOLOGY, published by BEGELL HOUSE INC, is an essential journal in the field of immunology that has been contributing to the scientific discourse since 1980. With its ISSN 1040-8401 and E-ISSN 2162-6472, this journal provides a platform for critical analysis and comprehensive reviews that deepen understanding of immune responses and their implications in health and disease. Although currently categorized in the Q4 quartile for Immunology and Q3 for Immunology and Allergy, the journal's quality research and scholarly contributions are crucial for advancing knowledge within its fields—encompassing various aspects of innate and adaptive immunity. Researchers and professionals in immunology will find invaluable insights, aiding them in their quest for innovation and excellence, as the journal aims to foster interdisciplinary collaboration. While it does not operate on an open-access model, CRITICAL REVIEWS IN IMMUNOLOGY remains a significant resource for those dedicated to pushing the boundaries of immunology, with annual publications expected to last well into 2024 and beyond.